These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 3594587

  • 21. The effects of liver and renal disease on stereoselective serum binding of flurbiprofen.
    Blouin R, Chaudhary I, Nishihara K, Cox S.
    Br J Clin Pharmacol; 1993 Jan; 35(1):62-4. PubMed ID: 8448071
    [Abstract] [Full Text] [Related]

  • 22. Plasma protein binding of phenytoin in health and disease: relevance to therapeutic drug monitoring.
    Perucca E.
    Ther Drug Monit; 1980 Jan; 2(4):331-44. PubMed ID: 7013166
    [Abstract] [Full Text] [Related]

  • 23. Plasma protein binding of alpidem in healthy volunteers, in neonates and in liver or renal insufficiency.
    Pacifici GM, Bianchetti G, Viani A, Rizzo G, Carrai M, Allen J, Morselli PL.
    Eur J Clin Pharmacol; 1989 Jan; 37(1):29-32. PubMed ID: 2574111
    [Abstract] [Full Text] [Related]

  • 24. [Blood urea in hepatopathies and nephropathies].
    GARCIA ROSSO E.
    Laboratorio; 1961 Jul; 32():15-36. PubMed ID: 13703528
    [No Abstract] [Full Text] [Related]

  • 25. [Interference of digoxin-like immunoreactive substance in the analysis of digoxin in pulmonary pathology: preliminary results].
    Romano L, Zofra S, Imperato G, Adorno V, Maglione A.
    Arch Monaldi; 1985 Jul; 40(3-4):157-64. PubMed ID: 3842060
    [No Abstract] [Full Text] [Related]

  • 26. [Paper electrophoretic study of lipoproteins in semeiology of liver diseases and in relation to fatty infiltration of the liver].
    SALVATORI L, PRATESI G, ZAMBONI L.
    Policlinico Med; 1957 Jul; 64(6):436-54. PubMed ID: 13527200
    [No Abstract] [Full Text] [Related]

  • 27. Protein binding of tolfenamic acid in the plasma from patients with renal and hepatic disease.
    Láznícek M, Senius KE.
    Eur J Clin Pharmacol; 1986 Jul; 30(5):591-6. PubMed ID: 3758148
    [Abstract] [Full Text] [Related]

  • 28. Investigation of the hexosamines loosely bound to the serum proteins in various diseases.
    Módy EJ.
    Med Interne; 1980 Jul; 18(4):421-3. PubMed ID: 7455588
    [No Abstract] [Full Text] [Related]

  • 29. Pharmacokinetics of ceftriaxone in patients with renal and liver insufficiency and correlations with a physiologic nonlinear protein binding model.
    Stoeckel K, Koup JR.
    Am J Med; 1984 Oct 19; 77(4C):26-32. PubMed ID: 6093514
    [Abstract] [Full Text] [Related]

  • 30. [Action of cephalothin on the blood "in vitro": influence of some plasmatic components on the sensitivity of the erythrocytes to the drug].
    Ferrone S, Mercuriali F, Zanella A.
    G Clin Med; 1968 Sep 19; 49(9):870-84. PubMed ID: 5716825
    [No Abstract] [Full Text] [Related]

  • 31. Plasma carbamylated protein in renal failure.
    Oimomi M, Ishikawa K, Kawasaki T, Kubota S, Yoshimura Y, Baba S.
    N Engl J Med; 1983 Mar 17; 308(11):655-6. PubMed ID: 6828101
    [No Abstract] [Full Text] [Related]

  • 32. Computer-assisted blood background subtraction (CABBS) renography in obstructive nephropathy.
    Britton KE, Brown NJ.
    Proc R Soc Med; 1970 Dec 17; 63(12):1246-7. PubMed ID: 5490775
    [No Abstract] [Full Text] [Related]

  • 33. Serum protein binding of valproic acid in healthy subjects and in patients with liver disease.
    Urien S, Albengres E, Tillement JP.
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul 17; 19(7):319-25. PubMed ID: 6790449
    [Abstract] [Full Text] [Related]

  • 34. [Studies of serum complement activity].
    BRUCKNER I, PURICE S.
    Med Interna (Bucur); 1958 Apr 17; 10(4):535-40. PubMed ID: 13565081
    [No Abstract] [Full Text] [Related]

  • 35. Characteristics of serum protein binding of felodipine.
    Valle M, Esteban M, Rodríguez-Sasiaín JM, Calvo R, Aguirre C.
    Res Commun Mol Pathol Pharmacol; 1996 Oct 17; 94(1):73-88. PubMed ID: 8948016
    [Abstract] [Full Text] [Related]

  • 36. [Age dependent changes in the serum melatonin concentrations in healthy human subjects and in patients with endocrine and hepatic disorders and renal failure (author's transl)].
    Iguchi H.
    Fukuoka Igaku Zasshi; 1981 Jul 17; 72(7):423-30. PubMed ID: 7308968
    [No Abstract] [Full Text] [Related]

  • 37. Plasma binding of pancuronium: effects of age, sex, and disease.
    Wood M, Stone WJ, Wood AJ.
    Anesth Analg; 1983 Jan 17; 62(1):29-32. PubMed ID: 6849508
    [Abstract] [Full Text] [Related]

  • 38. [Pharmacokinetics of simultaneously administered 99mTc-DTPA and (125I)ortho-iodohippuran in rats and rabbits].
    Láznícková A, Láznícek M, Kvĕtina J, Kraus K, Kusák V.
    Cesk Farm; 1985 Mar 17; 34(2):67-70. PubMed ID: 3891107
    [No Abstract] [Full Text] [Related]

  • 39. [Action of heparin and protamine sulfate administration on serum complement levels in a group of subjects with diseases with immunological pathogenesis].
    Di Perri T, Auteri A.
    Boll Soc Ital Biol Sper; 1970 Oct 30; 46(20):819-21. PubMed ID: 5519565
    [No Abstract] [Full Text] [Related]

  • 40. [Recent acquisitions on the pathogenesis of hyperammoniemia: clinico-experimental study on a new anti-ammonia drug].
    Furiosi P, Mercati U, Pasquini F.
    Minerva Med; 1967 Feb 21; 58(15):553-63. PubMed ID: 6021622
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.